Daisuke Kodama

Daisuke Kodama

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in European Journal of Pharmacology
Verified
Journal Article
Closed access
DKDaisuke Kodama
Daisuke Kodama
HOHideki Ono
Hideki Ono
MTMitsuo Tanabe
Mitsuo Tanabe

1 April 2011 in Pain
Verified
Journal Article
Closed access
DKDaisuke Kodama
Daisuke Kodama
HOHideki Ono
Hideki Ono
MTMitsuo Tanabe
Mitsuo Tanabe
Patients with chronic pain often have accompanying cognitive deficiency, which may reduce their quality of life and hamper efficient medical treatment. Alteration of extracellular glycine concentration may affect cognitive function and spinal pain signaling. In the present study, we assessed recognition memory by novel-object recognition and found that mice developing mechanical hypersensitivity after peripheral nerve injury exhibited impaired recognition ability for novelty, which was never observed in mice provided the selective glycine transporter 1 (GlyT1) inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy) propyl] sarcosine (NFPS) systemically. Although systemic NFPS generated analgesia via inhibitory effects of glycine in the spinal cord, the cognitive impairment in neuropathic mice was not restored upon relief of pain alone by intrathecal injection of NFPS. Whole-cell recordings were then made from hippocampal CA1 pyramidal neurons, and the effect of exogenously applied glycine or its endogenous increase by blockade of GlyT1 with NFPS on N-methyl-D-aspartate receptor-mediated excitatory postsynaptic currents (NMDA-EPSCs) was investigated in slices prepared from neuropathic mice and mice subjected to sham treatment. In slices from neuropathic mice, NMDA-EPSCs were less potentiated by glycine, whereas they were augmented by NFPS even at lower concentrations. After treating the slices with either NFPS or the glial-selective metabolic blocker fluoroacetate, glycine potentiated NMDA-EPSCs equally in slices from neuropathic and sham-treated mice. These findings imply that chronic pain has a crucial influence on hippocampal plasticity related to cognitive function, and strongly suggest that increasing the extracellular level of glycine via blockade of GlyT1 is a potential therapeutic approach for chronic pain with memory impairment. (C) 2010 International Association for the Study of Pain. Published by Elsevier B. V. All rights reserved.

1 May 2008 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
MTMitsuo Tanabe
Mitsuo Tanabe
KTKeiko Takasu
Keiko Takasu
SYSachiko Yamaguchi
Sachiko Yamaguchi
DKDaisuke Kodama
Daisuke Kodama
HOHideki Ono
Hideki Ono
Background: Impaired excitatory and inhibitory balance in the spinal dorsal horn has a crucial role in the pathophysiology of chronic pain. The authors addressed the therapeutic impact of increasing spinal glycine applied exogenously or via blockade of glycine transporter 1 using its selective inhibitors sarcosine and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine on neuropathic and inflammatory pain in mice. Methods: Mice with thermal and mechanical hypersensitivity after partial ligation of the sciatic nerve (Seltzer model) or mice with mechanical hypersensitivity after streptozotocin injection received intrathecal injection of glycine, sarcosine, and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine. These drugs were also intrathecally injected in mice to assess their effects on formalin-evoked nociceptive behaviors. The supraspinal effect of blockade of glycine transporter 1 was studied on tetanus-induced long-term potentiation of the Schaffer-collateral synapses in hippocampal slices prepared from Seltzer model mice. Results: Glycine, sarcosine, and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine ameliorated thermal and mechanical hypersensitivity in Seltzer model mice, and reduced mechanical hypersensitivity in streptozotocin-injected diabetic mice. Moreover, they selectively inhibited the second phase of formalin-evoked licking/biting behavior. In hippocampal slices prepared from Seltzer model mice, long-term potentiation was maintained at a significantly lower level than that in sham-treated mice. Such impairment of long-term potentiation was never observed when it was induced in the presence of N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine. Conclusions: An increase in endogenous glycine via glycine transporter 1 blockade not only results in a net inhibitory influence on pain transmission at the spinal level but also supraspinally relieves decreased synaptic efficacy presumably related to cognitive disturbance often described in patients with chronic pain.

22 February 2016 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
KTKenjiro Tanaka
Kenjiro Tanaka
THTakao Hirai
Takao Hirai
DKDaisuke Kodama
Daisuke Kodama
HKHisataka Kondo
Hisataka Kondo
KHKazunori Hamamura
Kazunori Hamamura
ATAkifumi Togari
Akifumi Togari

12 October 2012 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
DKDaisuke Kodama
Daisuke Kodama
ATA Togari
A Togari
Background and Purpose: Recent studies demonstrated that the sympathetic nervous system regulates bone metabolism via β2‐adrenoceptors. Although α‐adrenoceptors are also expressed in osteogenic cells, their functions in bone metabolism have been less studied. We previously demonstrated that noradrenaline suppressed potassium currents via α1B‐adrenoceptors in the human osteoblastSaM‐1 cell line. The aim of this study was to investigate the signal transduction pathway and the physiological role of noradrenaline in human osteoblasts in more detail.Experimental Approach: To investigate signal transduction through α1B‐adrenoceptors, we used whole‐cell patch clamp recording andCafluorescence imaging. Potassium channels regulate membrane potential and cell proliferation activity in non‐excitable cells, so we evaluated cell proliferation activity byBrdUincorporation andWSTassay.Key Results: InSaM‐1 cells, bath‐applied noradrenaline elevated intracellularCa2+concentration and this effect was abolished by both chloroethylclonidine, an α1B‐adrenoceptor antagonist, andU73122, a PLCinhibitor. However, the inhibitory effect of noradrenaline on whole‐cell current was unaffected byU73122. In contrast, in cells pretreated with eitherPertussistoxin, aGi/o‐protein‐coupled receptor inhibitor, or gallein, aGβγ‐protein inhibitor, the inhibitory effect of noradrenaline on whole‐cell current was significantly suppressed. Noradrenaline‐induced enhancement of cell proliferation was inhibited byCsCl, a non‐selective potassium channel blocker, gallein andH89, a PKAinhibitor, but not byU73122.Conclusions and Implications: Noradrenaline facilitated cell proliferation by regulation of potassium currents in human osteoblasts viaGi/o‐protein‐coupled α1B‐adrenoceptors, not via couplingto Gq‐proteins.